Ronald Blue & Co’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Ronald Blue & Co's LLY Position: Q2 2017 in Review
Ronald Blue & Co reduced its Eli Lilly (LLY) stake by 8.3% in Q2 2017, selling an estimated $341K and leaving 46,416 shares worth $3.82M. The position accounts for 0.12% of the portfolio, ranked #30.
Ronald Blue & Co first reported a position in LLY in Q2 2013 and has held it in 17 quarters since. The position peaked at $5.67M in Q2 2015. 1,247 funds tracked by Wall St. Rank hold LLY as of Q2 2017.
- Ronald Blue & Co held 46,416 shares of Eli Lilly worth $3.82M as of Q2 2017.
- Ronald Blue & Co sold 4,181 Eli Lilly shares in Q2 2017, an estimated $341K.
- Eli Lilly made up 0.12% of Ronald Blue & Co's portfolio in Q2 2017, its #30 holding.
- Ronald Blue & Co first reported a position in Eli Lilly in Q2 2013 and has held it in 17 quarters since.
- Ronald Blue & Co's Eli Lilly position peaked at $5.67M in Q2 2015.
- 1,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2017.
Based on Ronald Blue & Co's 13F filing for Q2 2017, filed 28 Jul 2017.